Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Hige

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 9, 2017
Analysis of hepatitis B surface antigen (HBsAg) using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assaysItaru Ozeki, Tomoaki Nakajima, Hirokazu Suii, et al.
Case Reports in Hepatology|January 30, 2018
Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to RibavirinHirokazu Suii, Itaru Ozeki, Ryoji Tatsumi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalitiesHiroshi Taguchi, Yusuke Sakuhara, Shuhei Hige, et al.
Journal of Viral Hepatitis|January 2, 2024
Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis BShuhei Hige, Kouji Aoki, Daisuke Nakamoto, et al.
Annals of Surgical Oncology|September 20, 2011
Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinomaMitsuru Nakanishi, Makoto Chuma, Shuhei Hige, et al.
Transplantation|March 9, 2005
Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infectionMasahiro Onozawa, Satoshi Hashino, Koh Izumiyama, et al.
Journal of Gastroenterology|November 21, 2020
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of JapanHirayuki Enomoto, Yoshiyuki Ueno, Yoichi Hiasa, et al.
Journal of Gastroenterology|November 27, 2019
Transition in the etiology of liver cirrhosis in Japan: a nationwide surveyHirayuki Enomoto, Yoshiyuki Ueno, Yoichi Hiasa, et al.
Journal of Gastroenterology|October 19, 2014
Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver diseaseMasanori Abe, Teruki Miyake, Atsushi Kuno, et al.
Liver Cancer|May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 9, 2017
Analysis of hepatitis B surface antigen (HBsAg) using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assaysItaru Ozeki, Tomoaki Nakajima, Hirokazu Suii, et al.
Case Reports in Hepatology|January 30, 2018
Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to RibavirinHirokazu Suii, Itaru Ozeki, Ryoji Tatsumi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalitiesHiroshi Taguchi, Yusuke Sakuhara, Shuhei Hige, et al.
Journal of Viral Hepatitis|January 2, 2024
Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis BShuhei Hige, Kouji Aoki, Daisuke Nakamoto, et al.
Annals of Surgical Oncology|September 20, 2011
Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinomaMitsuru Nakanishi, Makoto Chuma, Shuhei Hige, et al.
Transplantation|March 9, 2005
Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infectionMasahiro Onozawa, Satoshi Hashino, Koh Izumiyama, et al.
Journal of Gastroenterology|November 21, 2020
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of JapanHirayuki Enomoto, Yoshiyuki Ueno, Yoichi Hiasa, et al.
Journal of Gastroenterology|November 27, 2019
Transition in the etiology of liver cirrhosis in Japan: a nationwide surveyHirayuki Enomoto, Yoshiyuki Ueno, Yoichi Hiasa, et al.
Journal of Gastroenterology|October 19, 2014
Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver diseaseMasanori Abe, Teruki Miyake, Atsushi Kuno, et al.
Liver Cancer|May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Pageof 8